CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 300 enrolled
Drug / intervention
CoMiSS questionnaireother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03004729
NCT03004729N/ACompleted

Symptoms Based Awareness Confirmation Study - CoMiSS Validation

Société des Produits Nestlé (SPN)·interventional·Posted Dec 29, 2016·Updated Aug 20, 2018

In Brief

A clinical study evaluating CoMiSS questionnaire for Cow Milk Allergy. Completed, enrolled 300 participants across 10 sites.

Detailed Summary

The Cow's Milk-related Symptom Score (CoMiSS) tool has been developed to define a score to recognize cow's milk related symptoms in infants and young children. Many infants and toddlers with symptoms that can be related to intake of cow's milk and cow's milk protein allergy (CMPA) are often not diagnosed due to the lack of specific markers. The goal of this trial is to validate the CoMiSS tool in infants suspected of CMPA and investigate if the CoMiSS tool could be an alternative to the open challenge test needed to confirm the diagnosis of Cow Milk Protein Allergy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedDec 29, 2016
Enrollment StartDec 1, 2016
Primary CompletionJan 1, 2018
Study CompletionJul 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 9.5 years ago

Interventions

CoMiSS questionnaireother